🔴 Neurosense Therapeutics is trading 5.3% down today amid low-liquidity after-hours volatility

Neurosense Therapeutics is trading at $0.44 (5.3% down) in after-hours trading, slipping back after a modest regular-session rebound.

• The decline likely reflects typical after-hours volatility driven by thin liquidity and small orders having an outsized impact rather than a new fundamental development.
• There are no fresh company-specific headlines, earnings releases, or major biotech-sector catalysts tied to this move.